TBIO
Price:
$0.38
Market Cap:
$674.82K
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits that contain building blocks and reagents, including its Gibson Assembly branded reagents, for specific synthetic biology workflow applications; Cloud-based scripts; Benchtop r...[Read more]
Industry
Medical - Devices
IPO Date
2021-06-18
Stock Exchange
NASDAQ
Ticker
TBIO
According to Telesis Bio, Inc.’s latest financial reports and current stock price. The company's current ROE is -280.28%. This represents a change of 181.86% compared to the average of -99.44% of the last 4 quarters.
The mean historical ROE of Telesis Bio, Inc. over the last ten years is 10.25%. The current -280.28% ROE has changed -2833.60% with respect to the historical average. Over the past ten years (40 quarters), TBIO's ROE was at its highest in in the March 2021 quarter at 22.76%. The ROE was at its lowest in in the September 2024 quarter at -171.45%.
Average
10.25%
Median
55.90%
Minimum
-161.57%
Maximum
110.65%
Discovering the peaks and valleys of Telesis Bio, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.70%
Maximum Annual ROE = 110.65%
Minimum Annual Increase = -479.13%
Minimum Annual ROE = -161.57%
Year | ROE | Change |
---|---|---|
2023 | -161.57% | -479.13% |
2022 | 42.62% | -199.31% |
2021 | -42.91% | -160.66% |
2020 | 70.74% | -36.07% |
2019 | 110.65% | -242.35% |
2018 | -77.73% | -209.40% |
2017 | 71.05% | 2.70% |
The current ROE of Telesis Bio, Inc. (TBIO) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-53.96%
5-year avg
3.90%
10-year avg
10.25%
Telesis Bio, Inc.’s ROE is
Company | ROE | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Telesis Bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Telesis Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Telesis Bio, Inc.'s ROE?
How is the ROE calculated for Telesis Bio, Inc. (TBIO)?
What is the highest ROE for Telesis Bio, Inc. (TBIO)?
What is the 3-year average ROE for Telesis Bio, Inc. (TBIO)?
What is the 5-year average ROE for Telesis Bio, Inc. (TBIO)?
How does the current ROE for Telesis Bio, Inc. (TBIO) compare to its historical average?